Monographie - Telavancin hydrochloride

Son güncelleme :
08/05/2024

Telavancin hydrochloride

Kimyasal yapı

Ticari isim

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Vibativ

Amerika Birleşik Devletleri, Büyük Britanya, Kanada

Kaynaklar : Telavancin hydrochloride

	Tip	Yayın
2006	Dergi	Gu Z, Wong A, Raquinio E, Nguyen A. Stability of Reconstituted Telavancin Drug Product in Frozen Intravenous Bags. Hosp Pharm 2015 ; 50, 7: 609-614.
3254	Dergi	Housman S.T, Tessier P.R, Nicolau D.P, Kuti J.L. Physical compatibility of telavancin hydrochloride with select i.v. drugs during simulated Y-site administration Am J Health-Syst Pharm 2011 ; 68: 2265-2270.
3260	Laboratuar	Telavancin (Vibativ®) - Summary of Products characteristics Astellas Pharma Europe 2011
3327	Dergi	LaPlante K.L, Woodmansee S, Mermel L.A. Compatibility and stability of telavancin and vancomycin in heparin or sodium citrate lock solutions. Am J Health-Syst Pharm 2012 ; 69:1405-1409
3835	Dergi	Sand P, Aladeen T, Kirkegaard P, LaChance D, Slover C. Chemical Stability of Telavancin in Elastomeric Pumps. Current Ther Res 2015 ; 77: 99-104.
3839	Dergi	Gu Z, Parra C, Wong A, Nguyen A, Cheung R, Catalano T. Post-reconstitution Stability of Telavancin with Commonly Used Diluents and Intravenous Infusion Solutions. Current Ther Res 2015 ; 77: 105-110.

Mentions Légales